Torrent Pharmaceuticals Limited

NSEI:TORNTPHARM Lagerbericht

Marktkapitalisierung: ₹1.1t

Torrent Pharmaceuticals Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Samir Mehta

Geschäftsführender

₹260.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts0.02%
Amtszeit als Geschäftsführer35.8yrs
Eigentum des Geschäftsführers0.0002%
Durchschnittliche Amtszeit des Managements2.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.4yrs

Jüngste Management Updates

Recent updates

Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Oct 29
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Oct 24
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 26
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Apr 16
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 03
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Jan 07
Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Nov 14
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jun 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Mar 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 25
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Jun 02
Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

May 25
Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Feb 18
A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Jan 27
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Jan 04
Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

Dec 14
Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Nov 07
A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Sep 30
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Sep 01
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 02
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Jun 01
I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

May 14
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 23
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Samir Mehta im Vergleich zu den Einnahmen von Torrent Pharmaceuticals verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

₹18b

Jun 30 2024n/an/a

₹17b

Mar 31 2024₹260m₹40k

₹17b

Dec 31 2023n/an/a

₹15b

Sep 30 2023n/an/a

₹13b

Jun 30 2023n/an/a

₹13b

Mar 31 2023₹230m₹40k

₹12b

Dec 31 2022n/an/a

₹8b

Sep 30 2022n/an/a

₹8b

Jun 30 2022n/an/a

₹8b

Mar 31 2022₹200m₹40k

₹8b

Dec 31 2021n/an/a

₹12b

Sep 30 2021n/an/a

₹13b

Jun 30 2021n/an/a

₹13b

Mar 31 2021₹200m₹40k

₹13b

Dec 31 2020n/an/a

₹12b

Sep 30 2020n/an/a

₹12b

Jun 30 2020n/an/a

₹11b

Mar 31 2020₹200m₹40k

₹10b

Dec 31 2019n/an/a

₹6b

Sep 30 2019n/an/a

₹6b

Jun 30 2019n/an/a

₹5b

Mar 31 2019₹150m₹40k

₹4b

Dec 31 2018n/an/a

₹8b

Sep 30 2018n/an/a

₹6b

Jun 30 2018n/an/a

₹7b

Mar 31 2018₹150m₹40k

₹7b

Vergütung im Vergleich zum Markt: SamirDie Gesamtvergütung ($USD3.08M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD1.08M).

Entschädigung vs. Einkommen: SamirDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Samir Mehta (60 yo)

35.8yrs

Amtszeit

₹260,040,000

Vergütung

Mr. Samir Uttamlal Mehta, B.Com., MBA serves as a Managing Director of Torrent Pharmaceuticals Limited since 1989. Mr. Mehta served as Managing Director of Torrent Power Limited. Mr. Mehta has been associa...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Samir Mehta
Executive Chairman & MDno data₹260.04m0.00024%
₹ 2.6m
Aman Mehta
Whole-Time Director2.3yrs₹65.88m0.000060%
₹ 650.6k
Sudhir Menon
Chief Financial Officer6.2yrs₹16.30mkeine Daten
Chintan Trivedi
Company Secretary & Compliance Officer2.3yrskeine Datenkeine Daten
Jaydip Bhatt
Vice President of Human Resourceno data₹6.56mkeine Daten
Ashish Hajarnish
Executive Directorless than a year₹8.25mkeine Daten
Abdullah Said Al Abri
Chief Customer Service Officer3.4yrskeine Datenkeine Daten
Sanjay Gupta
President and CEO of Torrent Pharma USAno datakeine Datenkeine Daten

2.3yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrenes Management: TORNTPHARMDas Führungsteam des Unternehmens gilt als erfahren (2.3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Samir Mehta
Executive Chairman & MD35.8yrs₹260.04m0.00024%
₹ 2.6m
Aman Mehta
Whole-Time Director2.3yrs₹65.88m0.000060%
₹ 650.6k
Ashish Hajarnish
Executive Directorless than a year₹8.25mkeine Daten
Sudhir Mehta
Chairman Emeritus10.3yrskeine Daten0.00030%
₹ 3.3m
Nikhil Khattau
Independent Director1.1yrs₹2.60mkeine Daten
Manish Choksi
Independent Director2.3yrs₹4.30mkeine Daten
Ameera Shah
Independent Director6.3yrs₹4.90m0.00050%
₹ 5.4m
Nayantara Bali
Independent Director5.7yrs₹6.70mkeine Daten
Jinal Mehta
Non-Executive Directorless than a yearkeine Datenkeine Daten
Maurice Chagnaud
Independent Director2.5yrs₹6.30mkeine Daten

2.4yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrener Vorstand: TORNTPHARMDie Vorstandsmitglieder gelten nicht als erfahren ( 2.4 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.